Feedback / Questions
Tyvaso (treprostinil) - United Therapeutics Corporation, MannKind
Tyvaso: Newly added patent in Orange Book
(Orange Book)
-
Sep 9, 2026 -
Expiry on Mar 14, 2034
Patent
•
Interstitial Lung Disease • Pulmonary Arterial Hypertension • Respiratory Diseases
https://www.accessdata.fda.gov/scripts/cder/ob/search_patent.cfm?listed=new
Sep 9, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious